宏基因组学揭示慢性呼吸系统疾病中与微生物群相关的核心大环内酯类耐药组
Rationale: Long-term antibiotic use for managing chronic respiratory disease is increasing; however, the role of the airway resistome and its relationship to host microbiomes remains unknown.Objectives: To evaluate airway resistomes and relate them to host and environmental micro…
要点
- 气道存在核心耐药组,以大环内酯类为主,独立于疾病状态或抗生素暴露。
- Streptococcus和Actinomyces是大环内酯耐药基因ermX、ermF和msrD的关键潜在储库。
- 患者与吸入器微生物组及耐药组显著重叠,后者或可 proxy 评估气道微生物组。
核心结论
- 气道宏基因组分析揭示由宿主微生物群携带的核心大环内酯类耐药组。
研究设计与样本
- 构建基因-微生物共现网络以确定气道耐药组的潜在微生物来源,并比较31对患者-吸入器宏基因组以评估微生物组和/或耐药组的气道-环境重叠。
主要发现
- 气道宏基因组显示分类和代谢多样性以及独特的抗菌药物耐药模式。
- 存在以大环内酯类为主的核心气道耐药组,同时β-内酰胺类、氟喹诺酮类和四环素类耐药基因也高度流行,且独立于疾病状态或抗生素暴露。
- Streptococcus和Actinomyces是大环内酯耐药(包括ermX、ermF和msrD基因)的关键潜在微生物储库。
- 患者与吸入器在气道微生物组及其耐药组方面存在显著重叠,后者可能作为慢性呼吸系统疾病气道微生物组评估的替代指标。
临床怎么用
- 临床可关注气道核心耐药组尤其大环内酯类耐药基因的流行,其独立于疾病状态或抗生素暴露。
- 患者-吸入器微生物组及耐药组显著重叠,提示吸入器或可作为气道微生物组评估的替代采样对象。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Long-term antibiotic use for managing chronic respiratory disease is increasing; however, the role of the airway resistome and its relationship to host microbiomes remains unknown.Objectives: To evaluate airway resistomes and relate them to host and environmental microbiomes using ultradeep metagenomic shotgun sequencing.Methods: Airway specimens from 85 individuals with and without chronic respiratory disease (severe asthma, chronic obstructive pulmonary disease, and bronchiectasis) were subjected to metagenomic sequencing to an average depth exceeding 20 million reads. Respiratory and device-associated microbiomes were evaluated on the basis of taxonomical classification and functional annotation including the Comprehensive Antibiotic Resistance Database to determine airway resistomes. Co-occurrence networks of gene-microbe association were constructed to determine potential microbial sources of the airway resistome. Paired patient-inhaler metagenomes were compared (n = 31) to assess for the presence of airway-environment overlap in microbiomes and/or resistomes.Measurements and Main Results: Airway metagenomes exhibit taxonomic and metabolic diversity and distinct antimicrobial resistance patterns. A "core" airway resistome dominated by macrolide but with high prevalence of β-lactam, fluoroquinolone, and tetracycline resistance genes exists and is independent of disease status or antibiotic exposure. Streptococcus and Actinomyces are key potential microbial reservoirs of macrolide resistance including the ermX, ermF, and msrD genes. Significant patient-inhaler overlap in airway microbiomes and their resistomes is identified where the latter may be a proxy for airway microbiome assessment in chronic respiratory disease.Conclusions: Metagenomic analysis of the airway reveals a core macrolide resistome harbored by the host microbiome.
引用
- Mac Aogáin M, Lau KJX, Cai Z, et al. Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease. Am J Respir Crit Care Med. 2020. PMID: 32320621. doi:10.1164/rccm.201911-2202OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。